4-(6-chloro-2-methoxyacridin-9-ylamino)-2-hydroxybenzoic acid

ID: ALA1271378

Chembl Id: CHEMBL1271378

Cas Number: 5409-68-7

PubChem CID: 408297

Max Phase: Preclinical

Molecular Formula: C21H15ClN2O4

Molecular Weight: 394.81

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Synonyms: NSC-12509 | 5409-68-7|4-((6-Chloro-2-methoxy-9-acridinyl)amino)-2-hydroxybenzoic acid|CHEMBL1271378|NSC-12509|NSC12509|4-((6-Chloro-2-methoxyacridin-9-yl)amino)-2-hydroxybenzoic acid|NSC 12509|DTXSID40202425|BDBM50328833|4-(6-chloro-2-methoxyacridin-9-ylamino)-2-hydroxybenzoic acid|4-(6-Chloro-2-methoxyacridin-9-ylamino)-2-hydroxy- benzoic acid|4-[(6-chloro-2-methoxy-acridin-9-yl)amino]-2-hydroxy-benzoic acid|785712-53-0

Canonical SMILES:  COc1ccc2nc3cc(Cl)ccc3c(Nc3ccc(C(=O)O)c(O)c3)c2c1

Standard InChI:  InChI=1S/C21H15ClN2O4/c1-28-13-4-7-17-16(10-13)20(14-5-2-11(22)8-18(14)24-17)23-12-3-6-15(21(26)27)19(25)9-12/h2-10,25H,1H3,(H,23,24)(H,26,27)

Standard InChI Key:  PLQLHEGROOQNRO-UHFFFAOYSA-N

Associated Targets(Human)

PHLPP2 Tbio PH domain leucine-rich repeat-containing protein phosphatase 2 (32 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SRC Tclin Tyrosine-protein kinase SRC (10310 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KDR Tclin Vascular endothelial growth factor receptor 2 (20924 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TOP2A Tclin DNA topoisomerase II alpha (6317 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 394.81Molecular Weight (Monoisotopic): 394.0720AlogP: 5.20#Rotatable Bonds: 4
Polar Surface Area: 91.68Molecular Species: ACIDHBA: 5HBD: 3
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 3.36CX Basic pKa: 7.69CX LogP: 3.46CX LogD: 3.30
Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.41Np Likeness Score: -0.68

References

1. Sierecki E, Sinko W, McCammon JA, Newton AC..  (2010)  Discovery of small molecule inhibitors of the PH domain leucine-rich repeat protein phosphatase (PHLPP) by chemical and virtual screening.,  53  (19): [PMID:20836557] [10.1021/jm100331d]
2. Luan X, Gao C, Zhang N, Chen Y, Sun Q, Tan C, Liu H, Jin Y, Jiang Y..  (2011)  Exploration of acridine scaffold as a potentially interesting scaffold for discovering novel multi-target VEGFR-2 and Src kinase inhibitors.,  19  (11): [PMID:21576023] [10.1016/j.bmc.2011.04.053]

Source